Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 962 | 1137 | 1178 | 1455 | 1815 |
Fund Return | 5.71% | -3.82% | 13.75% | 5.6% | 7.79% | 6.14% |
Place in category | 1588 | 1953 | 1842 | 274 | 364 | 456 |
% in Category | 73 | 91 | 89 | 15 | 22 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Private Banking VermogensportfolPI4 | 164.38M | 6.94 | 0.80 | 3.73 | ||
Vermogensportfolio Nachh 70 AK 1 | 2.17B | 6.32 | 0.09 | 3.01 | ||
Private Banking Vermogensportfolio | 63.71M | 5.78 | 0.38 | 2.70 | ||
Private Banking VermogensportfolPI3 | 74.92M | 5.51 | 0.08 | 2.39 | ||
Amundi Substanzwerte | 79.63M | 8.70 | 2.18 | 2.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AriDeka CF | 2.86B | 8.03 | 3.81 | 5.83 | ||
Wellington Strategic European EquiS | 3.33B | 6.69 | 12.57 | 9.73 | ||
Wellington Strategic European EquiD | 3.33B | 2.38 | 10.85 | 8.83 | ||
Wellington Strategic European EquNE | 3.33B | 2.44 | 11.69 | 9.65 | ||
Allianz Industria A EUR | 1.54B | 3.84 | 2.29 | 6.16 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.38 | 745.4 | -0.73% | |
AstraZeneca | GB0009895292 | 4.32 | 10,474.0 | 0.00% | |
Roche Holding Participation | CH0012032048 | 4.09 | 253.50 | -0.31% | |
ASML Holding | NL0010273215 | 3.46 | 652.00 | +1.54% | |
Schneider Electric | FR0000121972 | 2.85 | 240.35 | -0.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review